Curian Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Curian Capital’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,638	Closed	-$1.32M	–	623
2015 Q1	$1.32M	Sell	7,638 -2,219	-23%	-$326K	0.02%	407
2014 Q4	$1.13M	Buy	9,857 +899	+10%	+$109K	0.02%	416
2014 Q3	$1.4M	Buy	8,958 +15	+0.2%	+$2.17K	0.02%	357
2014 Q2	$1.1M	Buy	8,943 +327	+4%	+$36.1K	0.02%	412
2014 Q1	$893K	Sell	8,616 -10,787	-56%	-$1.1M	0.02%	456
2013 Q4	$1.75M	Buy	19,403 +868	+5%	+$69.2K	0.03%	291
2013 Q3	$1.24M	Buy	18,535 +541	+3%	+$37.3K	0.02%	343
2013 Q2	$1.19M	Buy	+17,994	New	+$1.03M	0.02%	328

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Curian Capital's SLXP Position: Q2 2015 in Review

Curian Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 7,638 shares — an estimated $1.32M sold.

Curian Capital first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $1.75M in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Curian Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Curian Capital sold 7,638 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.32M.
Curian Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Curian Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.75M in Q4 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Curian Capital's 13F filing for Q2 2015, filed 28 Jul 2015.